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Between two and three per cent of Aus-
tralians suffer from rheumatoid arthritis, and
in addition to the pain and disability ex-
perienced by the individual patient there is
considerable cost to the community in terms
of loss of work, cost of prescriptions and
doctor's time. By an appreciation of the
natural history of the disease and the potential
value and disadvantages of the available treat-
ment methods, these costs may be reduced.
Rheumatoid arthritis is a chronic disease,
and although its natural history in anyone
patient is unpredictable, certain generali..
zations can be made. Of patients developing
definite rheumatoid arthritis of sufficient
severity to warrant hospitalization, 20% will
have short lived activity of joint disease which
remits without significant deformity; about
25% will remit with only mild or moderate
j oint changes; 40% will have persistent ac-
tivity of arthritis, punctuated by exacerbations
and remissions, leading eventually to fairly
marked deformity. Only about 10% will de-
velop severe progressive deforming disease,
leading to a wheel chair existence.
Males tend to fare better than females, and
the following features are associated with a
poorer prognosis:
(a) Insidious onset of disease;
(h) Persistence of active disease after one
year;
(c) Positive test for rheumatoid factor in the
first year of the disease;
(d) Early appearance of radiological erosions
or nodules.
Accepting that there is no specific cure for
rheumatoid arthritis, guidelines of treatment
should be marked out at an early stage. Each
treatment prescribed must have realistic,
clearly defined goals, and must be understood
by the patient. This requires the cooperation
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of physician, surgeon, physiotherapist, occu-
pational therapist, social worker and health
visitor. We can treat the patient with rest,
physiotherapy, drugs and surgery, and we
must also treat the environment by providing
appliances to assist with the activities of daily
living. l\1odifications may have to be made to
the home, and changes to occupational circum-
stances to allow the patient to continue to
work - one of the most important occupa..
tional therapies available. By a very thorough
understanding of the disease process, the doc..
tor and health worker are able to give en-
couragement and advice to a new rheumatoid
patient and establish a satisfactory therapist/
patient relationship, \\rhich is so important in
the treatment of this chronic disease. Family
and friends may have to be encouraged to
present an optimistic face to a depressed
patient, and in the case of single sufferers,
opportunities to join social organizations and
get out of the house should be explored. Lone..
liness is a tragically common accompaniment
to the elderly lvidowed patient with rheuma-
toid arthritis who is unable to get away from
home because of pain and deformity.
Rest can be useful during the acute phase
but there is no evidence to suggest that it
alters the course of the disease. Even in an
acute phase with total bed rest, active assisted
movements of all joints and static muscle
exercises to maintain power and tone, should
be performed twice daily. In the chronic
phase of the disease, exercises should he per-
formed as part of the daily routine, and each
,joint should be moved through as full a range
of movement as possible. Care should be taken
not to bring the chin forward on the chest for
fear of atlanto-axial dislocation, and patients
unable to sleep on one pillow should lie flat
for at least one hour each day. Pillows should
never he placed under the knees as this leads
to flexion deformities, and bed cradles should
be used to prevent foot drop.
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Rest with light splints, constructed of
padded polythene or plaster of Paris can be
very useful in relieving wrist and knee pain
at night when placed over the inflamed joint.
Serial splinting of the knees is used to treat
early flexion deformity, and splints to hold
joints in the best functional position is of
utmost importance in avoiding contractures
from poor bed posture in elderly bed-ridden
patients. Pain in the shoulders and upper arms
radiating from disease of the cervical spine
can be relieved quite markedly hy the use of
a soft padded collar of foam rubber or poly-
ethylene at night.
Hydrotherapy provides one of the best
methods of relaxation and moving the limbs
through a full range of movement. All patients
with rheumatoid arthritis should he encour-
aged to use it.
DRUG TREATMENT
The non-steroidal anti-inflammatory ,drugs
are used to suppress pain and inflammation.
They are used as the first line of treatment,
but have not been shown to alter the course of
the disease in any way. If patients cannot be
controlled with these agents, then gold or a
new drug, D-penicillamine, can be used.
Steroids are used in severe disease or in
acute flare..ups, but their side effects preclude
their use as maintenance therapy. In research
some of the drugs known as immuno-suppres-
sants are used. These drugs such as cyclo-
phosphamide and azathioprine are at present
being evaluated in the treatment of severe
disease where other forms of therapy have
failed.
Of the non-steroidal anti-inflammatory
drugs, aspirin is still the drug of first choice
(Ansell, 1969, and Hislop, 1972), though
studies hy Lee et al. (1974) suggest that this
rule is not always adhered to. Though daily
doses of 5 gm or more are required to provide
anti-inflammatory effect (Boardman and Hart,
1967) lower doses can achieve an adequate
analgesic effect (Lasagna, 1966). Aspirin has
been shown to he equal to corticosteroids in
relieving arthritic symptoms over a three-year
period (Bywaters, 1957), better than placebo
(Ragan, 1965), and equal to indomethacin in
effectiveness (Pinals and Frank, 1967).
Aust./.Physiother., XXII, 4, December, 1976
Aspirin needs to be pushed to the limit of
tolerance, using soluhle or enteric coated pre..
parations, at frequent intervals in order to
achieve stahle blood levels between 20 and
30 mgs per cent. Ringing in the ears (tinnitus)
serves as a good indicator to the doctor
that adequate levels of salicylate are being
achieved. The dose can then he reduced
slightly to alleviate this side effect. Enteric
coated aspirin tablets are sometimes better
tolerated from the point of view of gastric
irritation, and adequate blood levels can often
he achieved with a twice daily regime. One
of the most important things with aspirin
therapy, is to sell it to the patient. Many
patients have received it before in inadequate
doses or in doses which have caused severe
side effeets, and they also feel that a drug they
can buy over the counter cannot he as good
for them as a drug that comes on a prescrip-
tion only. To date there is no conclusive evi...
,dence that any of the newer non-steroidal
anti-inflammatory drugs are better than
aspirin in relieving pain and swelling in
rheumatoid arthritis.
Indomethacin is an extremely useful drug,
particularly from the point of view of re..
lieving morning stiffness. This can he achieved
by its administration orally or by suppository
at night. Indomethacin can sometimes produce
severe headache and dyspepsia and, very
rarely, blood disorders.
The pyrazoles, phenylbutazone and oxy-
phen-hutazone are effective as anti-rheumatic
agents, and have the advantage of once daily
administration. Care should be taken in elderly
patients because of the ability of the drug to
cause ankle oedema. Although blood disorders
have been reported, these are extremely rare.
Ihuprofen (Brufen) is the only one of the
phenylalkanoic acids group presently available
in Australia, though ketoprofen (Orudis)
naproxen (Naprosyn) and fen·oprofen (Feno-
pron) have all been used successfully over-
seas. None of these agents have been con-
clusively shown to be better than aspirin,
though it is still too early to assess their long
term effects.
Patients with rheumatoid arthritis receive a
multiplicity of drugs, and a significant pro..
portion receive two or more non-steroidal anti-
inflammatory agents together (Mason et al.,
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1975). There is no evidence to show that the
anti-inflammatory effects are additive, and at
present I feel that these agents should he used
singly.
If the non-steroidal anti-inflammatory drugs
fail to alleviate the symptoms of rheumatoid
arthritis, then gold or D-penicillamine should
be considered. Gold can be very useful in
controlling the disease (Sigler et al., 1974)
hut a close watch must he kept on the blood
count, and on the urine for any signs of gold
toxicity. Penicillamine is still in the process of
being critically evaluated and should only be
used in hospital where toxic side effects can
be monitored easily"
The use of corticosteroids is restricted to
severe cases, where there is evidence of vas-
culitis, where other measures have failed to
control the activities of the disease, or for
socioeconomic reasons, where it is essential
that the patient keep working. The danger of
corticosteroid therapy lies in the fact that
having achieved some relief, patient or prac-
titioner is tempted to increase the dose to toxic
levels in order to achieve a better short term
therapeutic result. Acute inflammatory epi-
sodes of rheumatoid arthritis can often be
controlled with bed rest, but corticotrophin
gel intramuscularly, or tetracosactrin (0.25
mgs) intramuscularly every two days for a
week are useful adjuncts. Intra·articular in-
jection of corticosteroid after aspiration of
a swollen joint (making sure that the aspirate
is not infected) can have a generalized as well
as a local effect, although the procedure should
only be repeated a few times for fear of
causing osteoarthritic changes in the injected
joints.
Finally, many patients with rheumatoid
arthritis are depressed, and in a clinical trial
of the use of imipramine, 75 mgs daily, with
patients on anti-rheumatic therapy, McDonald
Scott (1969) was able to show improvement
of function and a statistically significant pro-
portion of patients who noted a preference for
the active compounds.
Only by constant observation and indi..
vidualization of therapy can the patient with
rheumatoid arthritis be adequately treated.
A single non-steroidal anti-inflammatory drug
should be employed initially and the dose
carefully titrated to the patient's requirements
in both efficacy and toxicity ~ With persistence
minor intolerances can often he overcome and
the drug reintroduced and built up to an even
higher level.
Associated conditions, in particular anae-
mia, should be carefully watched for. Oral
iron therapy should not be persisted with
indefinitely in the absence of active gastro-
intestinal blood loss or a response to therapy.
Some patients will respond to intramuscular
iron., hut if the anaemia persists, consultant
advice should be sought. Anaemia in rheuma-
toid arthritis can have many causes and cor-
rect diagnosis and treatment is essential for
the continuing well-being of the patient.
SURGERY
Operative intervention can be extremely
useful in relieving pain from single joints or
restoring movement, stability, and function.
Surgery is reserved for specific instances as
there is as yet no evidence that it alters the
natural history of the disease. The question of
when to use surgery is a difficult one, but is
usually answered by the patient who presents
with a single persistently active problem joint.
Physiotherapy is essential both before and
after operation to strengthen the muscles
around the joint, and prevent fixation of
deformities.
The replacement of fused or persistently
painful hip joints has revolutionized the lives
of many patients with rheumatoid arthritis.
Knee synovectomy or replacement can rid a
patient of persistent pain and swelling, while
an osteotomy may stabilize a knee sufficiently
to enable a previously immobile patient to get
about, provided there is good function in the
other leg.
Pain in the foot is a continuing problem
with arthritic patients, and this can be treated
initially with metatarsal pads, and specially
moulded shoes. If pain persists, then operation
for removal of the metatarsal heads can relieve
much of the pain and disability.
Synovectomy, and insertion of artificial
joints into the metacarpophalangeal and inter-
phalangeal joints combined with tendon re-
pair, and wrist surgery has provided surgeons
with a golden opportunity to reconstruct
damaged hands. This reconstructive surgery
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to the hand and wrist has not been assessed
for long term effect, hut the initial results are
encouraging with functional improvement as
well as relief of pain. There is a mounting
feeling that early surgery may well preve~t
the deformities that we so commonly see In
rheumatoid patients, but it is always important
to place function before cosmetic appearance
when surgery is being considered.
Surgery for the elbows, shoulders and
ankles is at an early stage in development,
but research is progressing rapidly in this
area. Once again physiotherapy before and
after operation is essential for good surgical
outcome. Exercises should be begun from the
day of operation to prevent adhesions and
later restriction of movement.
One of the most important areas of help can
he in the provision of artificial aids and alter..
ing the home environment to enable the patient
to live as normal a life as possible. This can
only be achieved by visiting the patient's home
and assessing the patient in that environment.
Provision of raised toilet seats, hath seats,
rails for the shower, and hand rails or ramps
to aid the patient climbing steps, can he of
great value. This has been neglected in the
past, and it may not be realized that the pro-
vision of a raised toilet seat can often help
the patient more than trying them on a new
wonder drug.
A positive programme for the treatment of
rheumatoid arthritis, such as that outlined
ahove, involves the participation of all con-
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cerned, including the patient. It is hoped that
much good and more importantly, little harm,
will result for our patients with rheumatoid
arthritis.
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